α3β4 nicotinic acetylcholine receptors in the medial habenula modulate the mesolimbic dopaminergic response to acute nicotine in vivo

Neuropharmacology

Volumn 63, Issue 3, 2012, Pages 434-440

  McCallum, Sarah E ^a   Cowe, Matthew A ^a   Lewis, Samuel W ^a   Glick, Stanley D ^a  

^a ALBANY MEDICAL COLLEGE   (United States)

Author keywords

18 Methoxycoronaridine; Dopamine; Medial habenula; Microdialysis; Nicotine; Nicotinic receptor; Rat

Indexed keywords

18 METHOXYCORONARIDINE; AMPHETAMINE; CONOTOXIN; DOPAMINE; MORPHINE; NICOTINE; NICOTINIC RECEPTOR; NICOTINIC RECEPTOR BLOCKING AGENT;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; HABENULA; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VIVO STUDY; MESOLIMBIC DOPAMINERGIC SYSTEM; MICRODIALYSIS; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RAT;

ANIMALS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DEXTROAMPHETAMINE; DOPAMINE; DOPAMINE AGENTS; EXTRACELLULAR SPACE; FEMALE; HABENULA; IBOGAINE; LIMBIC SYSTEM; MICRODIALYSIS; MORPHINE; NARCOTICS; NICOTINE; NICOTINIC AGONISTS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, NICOTINIC;

EID: 84862023229     PISSN: 00283908     EISSN: 18737064     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2012.04.015     Document Type: Article

References (51)

1. M.E. Benwell, and D.J. Balfour The effects of acute and repeated nicotine treatment on nucleus accumbens dopamine and locomotor activity Br. J. Pharmacol. 105 1992 849 856
2. I.H. Bianco, and S.W. Wilson The habenular nuclei: a conserved asymmetric relay station in the vertebrate brain Philos. Trans. R. Soc. Lond. B Biol. Sci. 364 2009 1005 1020
3. L.J. Bierut, J.A. Stitzel, J.C. Wang, A.L. Hinrichs, R.A. Grucza, X. Xuei, N.L. Saccone, S.F. Saccone, S. Bertelsen, L. Fox, W.J. Horton, N. Breslau, J. Budde, C.R. Cloninger, D.M. Dick, T. Foroud, D. Hatsukami, V. Hesselbrock, E.O. Johnson, J. Kramer, S. Kuperman, P.A. Madden, K. Mayo, J. Nurnberger Jr., O. Pomerleau, B. Porjesz, O. Reyes, M. Schuckit, G. Swan, J.A. Tischfield, H.J. Edenberg, J.P. Rice, and A.M. Goate Variants in nicotinic receptors and risk for nicotine dependence Am. J. Psychiatry 165 2008 1163 1171
4. M.P. Brazell, S.N. Mitchell, M.H. Joseph, and J.A. Gray Acute administration of nicotine increases the in vivo extracellular levels of dopamine, 3,4-dihydroxyphenylacetic acid and ascorbic acid preferentially in the nucleus accumbens of the rat: comparison with caudate-putamen Neuropharmacology 29 1990 1177 1185
5. C. Cadoni, and G. Di Chiara Differential changes in accumbens shell and core dopamine in behavioral sensitization to nicotine Eur. J. Pharmacol. 387 2000 R23 R25
6. S. Chatterjee, P. Steensland, J.A. Simms, J. Holgate, J.W. Coe, R.S. Hurst, C.L. Shaffer, J. Lowe, H. Rollema, and S.E. Bartlett Partial agonists of the alpha3beta4* neuronal nicotinic acetylcholine receptor reduce ethanol consumption and seeking in rats Neuropsychopharmacology 36 2011 603 615
7. G.R. Christoph, R.J. Leonzio, and K.S. Wilcox Stimulation of the lateral habenula inhibits dopamine-containing neurons in the substantia nigra and ventral tegmental area of the rat J. Neurosci. 6 1986 613 619
8. P.B. Clarke, R.D. Schwartz, S.M. Paul, C.B. Pert, and A. Pert Nicotinic binding in rat brain: autoradiographic comparison of [3H]acetylcholine, [3H]nicotine, and [125I]-alpha-bungarotoxin J. Neurosci. 5 1985 1307 1315
9. Y. Dong, T. Zhang, W. Li, W.M. Doyon, and J.A. Dani Route of nicotine administration influences in vivo dopamine neuron activity: habituation, needle injection, and cannula infusion J. Mol. Neurosci. 40 2010 164 171
10. C.D. Fowler, Q. Lu, P.M. Johnson, M.J. Marks, and P.J. Kenny Habenular alpha5 nicotinic receptor subunit signalling controls nicotine intake Nature 471 2011 597 601
11. S. Frahm, M.A. Slimak, L. Ferrarese, J. Santos-Torres, B. Antolin-Fontes, S. Auer, S. Filkin, S. Pons, J.F. Fontaine, V. Tsetlin, U. Maskos, and I. Ibanez-Tallon Aversion to nicotine is regulated by the balanced activity of beta4 and alpha5 nicotinic receptor subunits in the medial habenula Neuron 70 2011 522 535
12. S. Geisler, and D.S. Zahm Afferents of the ventral tegmental area in the rat-anatomical substratum for integrative functions J. Comp. Neurol. 490 2005 270 294
13. S.D. Glick, M.E. Kuehne, I.M. Maisonneuve, U.K. Bandarage, and H.H. Molinari 18-Methoxycoronaridine, a non-toxic iboga alkaloid congener: effects on morphine and cocaine self-administration and on mesolimbic dopamine release in rats Brain Res. 719 1996 29 35
14. S.D. Glick, I.M. Maisonneuve, K.E. Visker, K.A. Fritz, U.K. Bandarage, and M.E. Kuehne 18-Methoxycoronardine attenuates nicotine-induced dopamine release and nicotine preferences in rats Psychopharmacology (Berl.) 139 1998 274 280
15. S.D. Glick, I.M. Maisonneuve, L.H. Hough, M.E. Kuehne, and U.K. Bandarage (+/-)-18-Methoxycoronaridine: a novel iboga alkaloid congener having potential anti-addictive efficacy CNS Drug Rev. 5 1999 27 42
16. S.D. Glick, I.M. Maisonneuve, and H.A. Dickinson 18-MC reduces methamphetamine and nicotine self-administration in rats Neuroreport 11 2000 2013 2015
17. S.D. Glick, I.M. Maisonneuve, B.A. Kitchen, and M.W. Fleck Antagonism of alpha 3 beta 4 nicotinic receptors as a strategy to reduce opioid and stimulant self-administration Eur. J. Pharmacol. 438 2002 99 105
18. S.D. Glick, R.L. Ramirez, J.M. Livi, and I.M. Maisonneuve 18-Methoxycoronaridine acts in the medial habenula and/or interpeduncular nucleus to decrease morphine self-administration in rats Eur. J. Pharmacol. 537 2006 94 98
19. S.D. Glick, E.M. Sell, and I.M. Maisonneuve Brain regions mediating alpha3beta4 nicotinic antagonist effects of 18-MC on methamphetamine and sucrose self-administration Eur. J. Pharmacol. 599 2008 91 95
20. S.D. Glick, E.M. Sell, S.E. McCallum, and I.M. Maisonneuve Brain regions mediating alpha3beta4 nicotinic antagonist effects of 18-MC on nicotine self-administration Eur. J. Pharmacol. 669 2011 71 75
21. C. Gotti, S. Guiducci, V. Tedesco, S. Corbioli, L. Zanetti, M. Moretti, A. Zanardi, R. Rimondini, M. Mugnaini, F. Clementi, C. Chiamulera, and M. Zoli Nicotinic acetylcholine receptors in the mesolimbic pathway: primary role of ventral tegmental area alpha6beta2* receptors in mediating systemic nicotine effects on dopamine release, locomotion, and reinforcement J. Neurosci. 30 2010 5311 5325
22. S.R. Grady, M. Moretti, M. Zoli, M.J. Marks, A. Zanardi, L. Pucci, F. Clementi, and C. Gotti Rodent habenulo-interpeduncular pathway expresses a large variety of uncommon nAChR subtypes, but only the alpha3beta4* and alpha3beta3beta4* subtypes mediate acetylcholine release J. Neurosci. 29 2009 2272 2282
23. M. Herkenham, and W.J. Nauta Afferent connections of the habenular nuclei in the rat. A horseradish peroxidase study, with a note on the fiber-of-passage problem J. Comp. Neurol. 173 1977 123 146
24. B.E. Hildebrand, G.G. Nomikos, P. Hertel, B. Schilstrom, and T.H. Svensson Reduced dopamine output in the nucleus accumbens but not in the medial prefrontal cortex in rats displaying a mecamylamine-precipitated nicotine withdrawal syndrome Brain Res. 779 1998 214 225
25. R.J. Hung, J.D. McKay, V. Gaborieau, P. Boffetta, M. Hashibe, D. Zaridze, A. Mukeria, N. Szeszenia-Dabrowska, J. Lissowska, P. Rudnai, E. Fabianova, D. Mates, V. Bencko, L. Foretova, V. Janout, C. Chen, G. Goodman, J.K. Field, T. Liloglou, G. Xinarianos, A. Cassidy, J. McLaughlin, G. Liu, S. Narod, H.E. Krokan, F. Skorpen, M.B. Elvestad, K. Hveem, L. Vatten, J. Linseisen, F. Clavel-Chapelon, P. Vineis, H.B. Bueno-de-Mesquita, E. Lund, C. Martinez, S. Bingham, T. Rasmuson, P. Hainaut, E. Riboli, W. Ahrens, S. Benhamou, P. Lagiou, D. Trichopoulos, I. Holcatova, F. Merletti, K. Kjaerheim, A. Agudo, G. Macfarlane, R. Talamini, L. Simonato, R. Lowry, D.I. Conway, A. Znaor, C. Healy, D. Zelenika, A. Boland, M. Delepine, M. Foglio, D. Lechner, F. Matsuda, H. Blanche, I. Gut, S. Heath, M. Lathrop, and P. Brennan A susceptibility locus for lung cancer maps to nicotinic acetylcholine receptor subunit genes on 15q25 Nature 452 2008 633 637
26. S. Janhunen, and L. Ahtee Comparison of the effects of nicotine and epibatidine on the striatal extracellular dopamine Eur. J. Pharmacol. 494 2004 167 177
27. S. Janhunen, P. Mielikainen, P. Paldanius, R.K. Tuominen, L. Ahtee, and S. Kaakkola The effect of nicotine in combination with various dopaminergic drugs on nigrostriatal dopamine in rats Naunyn Schmiedebergs Arch. Pharmacol. 371 2005 480 491
28. U. Kim, and S.Y. Chang Dendritic morphology, local circuitry, and intrinsic electrophysiology of neurons in the rat medial and lateral habenular nuclei of the epithalamus J. Comp. Neurol. 483 2005 236 250
29. T. Leikola-Pelho, J. Heinamaki, I. Laakso, and L. Ahtee Chronic nicotine treatment changes differentially the effects of acute nicotine on the three main dopamine metabolites in mouse striatum Naunyn Schmiedebergs Arch. Pharmacol. 342 1990 400 406
30. S. Luo, J.M. Kulak, G.E. Cartier, R.B. Jacobsen, D. Yoshikami, B.M. Olivera, and J.M. McIntosh alpha-conotoxin AuIB selectively blocks alpha3 beta4 nicotinic acetylcholine receptors and nicotine-evoked norepinephrine release J. Neurosci. 18 1998 8571 8579
31. I.M. Maisonneuve, and S.D. Glick Attenuation of the reinforcing efficacy of morphine by 18-methoxycoronaridine Eur. J. Pharmacol. 383 1999 15 21
32. M. Matsumoto, and O. Hikosaka Lateral habenula as a source of negative reward signals in dopamine neurons Nature 447 2007 1111 1115
33. C. Mulle, C. Vidal, P. Benoit, and J.P. Changeux Existence of different subtypes of nicotinic acetylcholine receptors in the rat habenulo- interpeduncular system J. Neurosci. 11 1991 2588 2597
34. T. Nishikawa, D. Fage, and B. Scatton Evidence for, and nature of, the tonic inhibitory influence of habenulointerpeduncular pathways upon cerebral dopaminergic transmission in the rat Brain Res. 373 1986 324 336
35. N. Omelchenko, R. Bell, and S.R. Sesack Lateral habenula projections to dopamine and GABA neurons in the rat ventral tegmental area Eur. J. Neurosci. 30 2009 1239 1250
36. C.J. Pace, S.D. Glick, I.M. Maisonneuve, L.W. He, P.A. Jokiel, M.E. Kuehne, and M.W. Fleck Novel iboga alkaloid congeners block nicotinic receptors and reduce drug self-administration Eur. J. Pharmacol. 492 2004 159 167
37. G. Paxinos, and C. Watson The Rat Brain in Stereotaxic Coordinates second ed. 1986 Academic Press
38. O.T. Phillipson, and C.J. Pycock Dopamine neurones of the ventral tegmentum project to both medial and lateral habenula. Some implications for habenular function Exp. Brain Res. 45 1982 89 94
39. M.R. Picciotto, M. Zoli, R. Rimondini, C. Lena, L.M. Marubio, E.M. Pich, K. Fuxe, and J.P. Changeux Acetylcholine receptors containing the beta2 subunit are involved in the reinforcing properties of nicotine Nature 391 1998 173 177
40. M.W. Quick, R.M. Ceballos, M. Kasten, J.M. McIntosh, and R.A. Lester Alpha3beta4 subunit-containing nicotinic receptors dominate function in rat medial habenula neurons Neuropharmacology 38 1999 769 783
41. S. Rahman, J. Zhang, E.A. Engleman, and W.A. Corrigall Neuroadaptive changes in the mesoaccumbens dopamine system after chronic nicotine self-administration: a microdialysis study Neuroscience 129 2004 415 424
42. S. Rahman, N.M. Neugebauer, Z. Zhang, P.A. Crooks, L.P. Dwoskin, and M.T. Bardo The novel nicotinic receptor antagonist N,N'-dodecane-1,12-diyl-bis-3- picolinium dibromide decreases nicotine-induced dopamine metabolism in rat nucleus accumbens Eur. J. Pharmacol. 601 2008 103 105
43. H. Rollema, L.K. Chambers, J.W. Coe, J. Glowa, R.S. Hurst, L.A. Lebel, Y. Lu, R.S. Mansbach, R.J. Mather, C.C. Rovetti, S.B. Sands, E. Schaeffer, D.W. Schulz, F.D. Tingley 3rd, and K.E. Williams Pharmacological profile of the alpha4beta2 nicotinic acetylcholine receptor partial agonist varenicline, an effective smoking cessation aid Neuropharmacology 52 2007 985 994
44. R. Salas, R. Sturm, J. Boulter, and M. De Biasi Nicotinic receptors in the habenulo-interpeduncular system are necessary for nicotine withdrawal in mice J. Neurosci. 29 2009 3014 3018
45. O. Salminen, T. Seppa, H. Gaddnas, and L. Ahtee The effects of acute nicotine on the metabolism of dopamine and the expression of Fos protein in striatal and limbic brain areas of rats during chronic nicotine infusion and its withdrawal J. Neurosci. 19 1999 8145 8151
46. T. Seppa, M. Ruotsalainen, I. Laakso, R. Tuominen, and L. Ahtee Effect of acute nicotine administration on striatal dopamine output and metabolism in rats kept at different ambient temperatures Br. J. Pharmacol. 130 2000 1147 1155
47. A.M. Struthers, J.L. Wilkinson, L.P. Dwoskin, P.A. Crooks, and R.A. Bevins Mecamylamine, dihydro-beta-erythroidine, and dextromethorphan block conditioned responding evoked by the conditional stimulus effects of nicotine Pharmacol. Biochem. Behav. 94 2009 319 328
48. R.J. Sutherland The dorsal diencephalic conduction system: a review of the anatomy and functions of the habenular complex Neurosci. Biobehav. Rev. 6 1982 1 13
49. K.K. Szumlinski, I.M. Maisonneuve, and S.D. Glick 18-Methoxycoronaridine differentially alters the sensitized behavioral and dopaminergic responses to repeated cocaine and morphine administration. Implications for sensitization in the mediation of drug addiction Ann. N. Y. Acad. Sci. 909 2000 275 279
50. O.D. Taraschenko, J.M. Shulan, I.M. Maisonneuve, and S.D. Glick 18-MC acts in the medial habenula and interpeduncular nucleus to attenuate dopamine sensitization to morphine in the nucleus accumbens Synapse 61 2007 547 560
51. E. Toth, H. Sershen, A. Hashim, E.S. Vizi, and A. Lajtha Effect of nicotine on extracellular levels of neurotransmitters assessed by microdialysis in various brain regions: role of glutamic acid Neurochem. Res. 17 1992 265 271